-
Symbol
-
PMN on Nasdaq
-
Investment type
-
Equity / Common Stock
-
Latest Disclosed Shares Owned
-
895,877 shares
-
Security Ownership %
-
10%
Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. ownership in ProMIS Neurosciences, Inc. Common Stock (PMN)
18 Mar 2026 - Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 895,877 shares of ProMIS Neurosciences, Inc. Common Stock (PMN).
This represents 10% ownership of the company.
This is the first filing by Wellington Biomedical Innovation Master Investors (Cayman) II L.P. disclosing ownership of ProMIS Neurosciences, Inc. Common Stock (PMN).